Year |
Citation |
Score |
2023 |
Trang P, Smith A, Liu F. Mapping of RNase P Ribozyme Regions in Proximity with a Human RNase P Subunit Protein Using Fe(II)-EDTA Cleavage and Nuclease Footprint Analyses. Methods in Molecular Biology (Clifton, N.J.). 2666: 55-67. PMID 37166656 DOI: 10.1007/978-1-0716-3191-1_4 |
0.695 |
|
2019 |
Deng Q, Liu Y, Li X, Yan B, Sun X, Tang W, Trang P, Yang Z, Gong H, Wang Y, Lu J, Chen J, Xia C, Xing X, Lu S, et al. Inhibition of human cytomegalovirus major capsid protein expression and replication by ribonuclease P-associated external guide sequences. Rna (New York, N.Y.). PMID 30803999 DOI: 10.1261/Rna.069682.118 |
0.812 |
|
2019 |
Liu W, Dai X, Jih J, Chan K, Trang P, Yu X, Balogun R, Mei Y, Liu F, Zhou ZH. Atomic structures and deletion mutant reveal different capsid-binding patterns and functional significance of tegument protein pp150 in murine and human cytomegaloviruses with implications for therapeutic development. Plos Pathogens. 15: e1007615. PMID 30779794 DOI: 10.1371/Journal.Ppat.1007615 |
0.547 |
|
2018 |
Li W, Liu Y, Wang Y, Li R, Trang P, Tang W, Yang Z, Wang Y, Sun X, Xing X, Lu S, Liu F. Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals. Theranostics. 8: 5634-5644. PMID 30555569 DOI: 10.7150/Thno.27776 |
0.753 |
|
2018 |
Chen YC, Sheng J, Trang P, Liu F. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections. Viruses. 10. PMID 29844277 DOI: 10.3390/V10060291 |
0.608 |
|
2018 |
Zhu D, Pan C, Sheng J, Liang H, Bian Z, Liu Y, Trang P, Wu J, Liu F, Zhang CY, Zen K. Human cytomegalovirus reprogrammes haematopoietic progenitor cells into immunosuppressive monocytes to achieve latency. Nature Microbiology. 3: 503-513. PMID 29588542 DOI: 10.1038/S41564-018-0131-9 |
0.571 |
|
2018 |
Feng L, Sheng J, Vu GP, Liu Y, Foo C, Wu S, Trang P, Paliza-Carre M, Ran Y, Yang X, Sun X, Deng Z, Zhou T, Lu S, Li H, et al. Human cytomegalovirus UL23 inhibits transcription of interferon-γ stimulated genes and blocks antiviral interferon-γ responses by interacting with human N-myc interactor protein. Plos Pathogens. 14: e1006867. PMID 29377960 DOI: 10.1371/Journal.Ppat.1006867 |
0.568 |
|
2017 |
Li W, Sheng J, Xu M, Vu GP, Yang Z, Liu Y, Sun X, Trang P, Lu S, Liu F. Inhibition of Murine Cytomegalovirus Infection in Animals by RNase P-Associated External Guide Sequences. Molecular Therapy. Nucleic Acids. 9: 322-332. PMID 29246310 DOI: 10.1016/J.Omtn.2017.10.007 |
0.791 |
|
2017 |
Sun X, Chen W, He L, Sheng J, Liu Y, Vu GP, Yang Z, Li W, Trang P, Wang Y, Hai R, Zhu H, Lu S, Liu F. Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant. Plos One. 12: e0186791. PMID 29059242 DOI: 10.1371/Journal.Pone.0186791 |
0.79 |
|
2016 |
Liu J, Shao L, Trang P, Yang Z, Reeves M, Sun X, Vu GP, Wang Y, Li H, Zheng C, Lu S, Liu F. Inhibition of herpes simplex virus 1 gene expression and replication by RNase P-associated external guide sequences. Scientific Reports. 6: 27068. PMID 27279482 DOI: 10.1038/Srep27068 |
0.835 |
|
2015 |
Yang Z, Reeves M, Ye J, Trang P, Zhu L, Sheng J, Wang Y, Zen K, Wu J, Liu F. RNase P Ribozymes Inhibit the Replication of Human Cytomegalovirus by Targeting Essential Viral Capsid Proteins. Viruses. 7: 3345-3360. PMID 26114473 DOI: 10.3390/V7072775 |
0.789 |
|
2013 |
Zeng W, Vu GP, Bai Y, Chen YC, Trang P, Lu S, Xiao G, Liu F. RNase P-associated external guide sequence effectively reduces the expression of human CC-chemokine receptor 5 and inhibits the infection of human immunodeficiency virus 1. Biomed Research International. 2013: 509714. PMID 23509733 DOI: 10.1155/2013/509714 |
0.817 |
|
2013 |
Xia C, Chen YC, Gong H, Zeng W, Vu GP, Trang P, Lu S, Wu J, Liu F. Inhibition of hepatitis B virus gene expression and replication by ribonuclease P. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 995-1003. PMID 23481322 DOI: 10.1038/Mt.2013.37 |
0.727 |
|
2012 |
Zeng W, Chen YC, Bai Y, Trang P, Vu GP, Lu S, Wu J, Liu F. Effective inhibition of human immunodeficiency virus 1 replication by engineered RNase P ribozyme. Plos One. 7: e51855. PMID 23300569 DOI: 10.1371/Journal.Pone.0051855 |
0.788 |
|
2012 |
Jiang X, Chen YC, Gong H, Trang P, Lu S, Liu F. Ribonuclease P-mediated inhibition of human cytomegalovirus gene expression and replication induced by engineered external guide sequences. Rna Biology. 9: 1186-95. PMID 23018778 DOI: 10.4161/Rna.21724 |
0.825 |
|
2012 |
Jiang X, Gong H, Chen YC, Vu GP, Trang P, Zhang CY, Lu S, Liu F. Effective inhibition of cytomegalovirus infection by external guide sequences in mice. Proceedings of the National Academy of Sciences of the United States of America. 109: 13070-5. PMID 22826233 DOI: 10.1073/Pnas.1201620109 |
0.77 |
|
2008 |
Trang P, Liu F. Mapping the regions of RNase P catalytic RNA that are potentially in close contact with its protein cofactor. Methods in Molecular Biology (Clifton, N.J.). 488: 267-77. PMID 18982298 DOI: 10.1007/978-1-60327-475-3_19 |
0.704 |
|
2008 |
Bai Y, Trang P, Li H, Kim K, Zhou T, Liu F. Effective inhibition in animals of viral pathogenesis by a ribozyme derived from RNase P catalytic RNA. Proceedings of the National Academy of Sciences of the United States of America. 105: 10919-24. PMID 18663226 DOI: 10.1073/Pnas.0804922105 |
0.868 |
|
2006 |
Li H, Trang P, Kim K, Zhou T, Umamoto S, Liu F. Effective inhibition of human cytomegalovirus gene expression and growth by intracellular expression of external guide sequence RNA. Rna (New York, N.Y.). 12: 63-72. PMID 16301604 DOI: 10.1261/Rna.2184706 |
0.848 |
|
2005 |
Dunn W, Trang P, Zhong Q, Yang E, van Belle C, Liu F. Human cytomegalovirus expresses novel microRNAs during productive viral infection. Cellular Microbiology. 7: 1684-95. PMID 16207254 DOI: 10.1111/J.1462-5822.2005.00598.X |
0.806 |
|
2005 |
Yu X, Trang P, Shah S, Atanasov I, Kim YH, Bai Y, Zhou ZH, Liu F. Dissecting human cytomegalovirus gene function and capsid maturation by ribozyme targeting and electron cryomicroscopy. Proceedings of the National Academy of Sciences of the United States of America. 102: 7103-8. PMID 15883374 DOI: 10.1073/Pnas.0408826102 |
0.766 |
|
2004 |
Kim K, Trang P, Umamoto S, Hai R, Liu F. RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins. Nucleic Acids Research. 32: 3427-34. PMID 15220469 DOI: 10.1093/Nar/Gkh660 |
0.839 |
|
2004 |
Zhu J, Trang P, Kim K, Zhou T, Deng H, Liu F. Effective inhibition of Rta expression and lytic replication of Kaposi's sarcoma-associated herpesvirus by human RNase P. Proceedings of the National Academy of Sciences of the United States of America. 101: 9073-8. PMID 15184661 DOI: 10.1073/Pnas.0403164101 |
0.876 |
|
2004 |
Zou H, Lee J, Kilani AF, Kim K, Trang P, Kim J, Liu F. Engineered RNase P ribozymes increase their cleavage activities and efficacies in inhibiting viral gene expression in cells by enhancing the rate of cleavage and binding of the target mRNA. The Journal of Biological Chemistry. 279: 32063-70. PMID 15169770 DOI: 10.1074/Jbc.M403059200 |
0.87 |
|
2004 |
Trang P, Kim K, Liu F. Developing RNase P ribozymes for gene-targeting and antiviral therapy. Cellular Microbiology. 6: 499-508. PMID 15104592 DOI: 10.1111/J.1462-5822.2004.00398.X |
0.864 |
|
2004 |
Trang P, Liu F. RNase P ribozyme as an antiviral agent against human cytomegalovirus. Methods in Molecular Biology (Clifton, N.J.). 252: 437-50. PMID 15017069 DOI: 10.1385/1-59259-746-7:437 |
0.77 |
|
2004 |
Zou H, Chan K, Trang P, Liu F. General design and construction of RNase P ribozymes for gene-targeting applications. Methods in Molecular Biology (Clifton, N.J.). 252: 385-98. PMID 15017065 DOI: 10.1385/1-59259-746-7:385 |
0.694 |
|
2004 |
Kim K, Umamoto S, Trang P, Hai R, Liu F. Intracellular expression of engineered RNase P ribozymes effectively blocks gene expression and replication of human cytomegalovirus. Rna (New York, N.Y.). 10: 438-47. PMID 14970389 DOI: 10.1261/Rna.5178404 |
0.834 |
|
2003 |
Zou H, Lee J, Umamoto S, Kilani AF, Kim J, Trang P, Zhou T, Liu F. Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells. The Journal of Biological Chemistry. 278: 37265-74. PMID 12867424 DOI: 10.1074/Jbc.M303531200 |
0.87 |
|
2003 |
Trang P, Kim K, Zhu J, Liu F. Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth. Journal of Molecular Biology. 328: 1123-35. PMID 12729746 DOI: 10.1016/S0022-2836(03)00398-X |
0.891 |
|
2002 |
Trang P, Kilani A, Lee J, Hsu A, Liou K, Kim J, Nassi A, Kim K, Liu F. RNase P ribozymes for the studies and treatment of human cytomegalovirus infections. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 25: S63-74. PMID 12361758 DOI: 10.1016/S1386-6532(02)00097-5 |
0.883 |
|
2002 |
Trang P, Lee J, Kilani AF, Kim J, Liu F. Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme. Nucleic Acids Research. 29: 5071-8. PMID 11812839 DOI: 10.1093/Nar/29.24.5071 |
0.825 |
|
2002 |
Trang P, Hsu A, Zhou T, Lee J, Kilani AF, Nepomuceno E, Liu F. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding. Journal of Molecular Biology. 315: 573-86. PMID 11812131 DOI: 10.1006/Jmbi.2001.5291 |
0.761 |
|
2001 |
Dunn W, Trang P, Khan U, Zhu J, Liu F. RNase P-mediated inhibition of cytomegalovirus protease expression and viral DNA encapsidation by oligonucleotide external guide sequences. Proceedings of the National Academy of Sciences of the United States of America. 98: 14831-6. PMID 11742095 DOI: 10.1073/Pnas.261560598 |
0.863 |
|
2000 |
Trang P, Kilani A, Kim J, Liu F. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1. Journal of Molecular Biology. 301: 817-26. PMID 10966788 DOI: 10.1006/Jmbi.2000.4022 |
0.823 |
|
2000 |
Liu F, Wang J, Trang P. In vitro selection of RNA substrates for ribonuclease P and its catalytic RNA. Methods in Enzymology. 318: 238-50. PMID 10889992 DOI: 10.1016/S0076-6879(00)18056-5 |
0.597 |
|
2000 |
Trang P, Lee M, Nepomuceno E, Kim J, Zhu H, Liu F. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America. 97: 5812-7. PMID 10811889 DOI: 10.1073/Pnas.100101797 |
0.822 |
|
2000 |
Kilani AF, Trang P, Jo S, Hsu A, Kim J, Nepomuceno E, Liou K, Liu F. RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture. The Journal of Biological Chemistry. 275: 10611-22. PMID 10744757 DOI: 10.1074/Jbc.275.14.10611 |
0.758 |
|
2000 |
Trang P, Hsu AW, Liu F. Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate. Nucleic Acids Research. 27: 4590-7. PMID 10556315 DOI: 10.1093/Nar/27.23.4590 |
0.698 |
|
Show low-probability matches. |